Legal Representation
Attorney
Mark J. Liss
USPTO Deadlines
Application History
9 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Apr 24, 2023 | MAB2 | E | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | Loading... |
| Apr 22, 2023 | MAB2 | O | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | Loading... |
| Apr 22, 2023 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
| Jan 4, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jan 4, 2023 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jan 4, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Dec 28, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Mar 22, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Mar 19, 2022 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Chemico-pharmaceutical preparations for treating glabellar lines, forehead wrinkles, lateral canthal line, migraine headache, overactive bladder, urge incontinence, prostate disorder, cervical dystonia, spasticity, muscle dystonia, blepharospasm, hyperhidrosis, strabismus, eye blinking, neuropathy pain and pelvic pain; pharmaceutical agents affecting sensory organs; pharmaceutical preparations for peripheral nervous system; bacterial poisons; pharmacological preparations for skin care, namely, pharmaceutical preparations for skin care; pharmaceutical agents for epidermis; injectable dermal fillers; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for treating skin disorders; biological preparations for medical or veterinary purposes for the treatment and prevention of neurological disorders and muscle dystonia; vaccines; medicated lotions for skin, hair, sunburn, face, body; implantable medicines for treating antiaging, neurological disorders and muscle dystonia; pharmaceuticals containing botulinum toxin for medical use for use in the treatment of glabellar lines, forehead wrinkles, lateral canthal line, migraine headache, overactive bladder, urge incontinence, prostate disorder, cervical dystonia, spasticity, muscle dystonia, blepharospasm, hyperhidrosis, strabismus, eye blinking, neuropathy pain and pelvic pain; pharmaceutical syringes prefilled with medical botulinum toxin as the main ingredient for medical use for use in the treatment of glabellar lines, forehead wrinkles, lateral canthal line, migraine headache, overactive bladder, urge incontinence, prostate disorder, cervical dystonia, spasticity, muscle dystonia, blepharospasm, hyperhidrosis, strabismus, eye blinking, neuropathy pain and pelvic pain; medicinal infusions for treating antiaging, neurological disorders and muscle dystonia
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005